{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T15:19:00Z","timestamp":1768317540296,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:00:00Z","timestamp":1675036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009142","name":"Cancer Care Ontario","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009142","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015539","name":"Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015539","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001171","name":"Cancer Institute NSW","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016056","name":"Minderoo Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016056","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tumour Virus Research"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.tvr.2023.200255","type":"journal-article","created":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T21:57:45Z","timestamp":1675202265000},"page":"200255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Exploring monitoring strategies for population surveillance of HPV vaccine impact using primary HPV screening"],"prefix":"10.1016","volume":"15","author":[{"given":"Louiza S.","family":"Velentzis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Hawkes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Caruana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia ML.","family":"Brotherton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara","family":"Roeske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khurram A.","family":"Karim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne M.","family":"Garland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. David","family":"Wrede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffery","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cosette","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip E.","family":"Castle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Saville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Canfell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tvr.2023.200255_bib3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(19)30298-3","article-title":"HPV Vaccination Impact Study Group, Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis","volume":"394","author":"Drolet","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.tvr.2023.200255_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/infdis\/jiu370","article-title":"Fall in genital warts diagnoses in the general and indigenous Australian population following implementation of a national human papillomavirus vaccination program: analysis of routinely collected national hospital data","volume":"211","author":"Smith","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tvr.2023.200255_bib6","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1093\/infdis\/jiy075","article-title":"Very low prevalence of vaccine human papillomavirus types among 18- to 35-year old Australian women 9 Years following implementation of vaccination","volume":"217","author":"Machalek","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tvr.2023.200255_bib9","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/ijc.28115","article-title":"Can clinical tests help monitor human papillomavirus vaccine impact?","volume":"133","author":"Meites","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tvr.2023.200255_bib10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1741-7015-9-104","article-title":"Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program","volume":"9","author":"Garland","year":"2011","journal-title":"BMC Med."},{"key":"10.1016\/j.tvr.2023.200255_bib11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1071\/SH15035","article-title":"Human papillomavirus prevalence to age 60 years amongst Australian women pre-vaccination","volume":"12","author":"Brotherton","year":"2015","journal-title":"Sex. Health"},{"key":"10.1016\/j.tvr.2023.200255_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002388","article-title":"Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: results of the COMPASS pilot randomised trial","volume":"14","author":"Canfell","year":"2017","journal-title":"PLoS Med."},{"key":"10.1016\/j.tvr.2023.200255_bib13","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jviromet.2006.02.007","article-title":"Human papillomavirus genotyping using a modified linear array detection protocol","volume":"135","author":"Stevens","year":"2016","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.tvr.2023.200255_bib14","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1128\/JCM.01169-08","article-title":"Validation of an automated detection platform for use with the Roche linear array human papillomavirus genotyping test","volume":"46","author":"Stevens","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.tvr.2023.200255_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1128\/JCM.05989-11","article-title":"PaP Cohort Study Group, Comparison of the cobas Human Papillomavirus (HPV) test with the hybrid capture 2 and linear array HPV DNA tests","volume":"50","author":"Gage","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.tvr.2023.200255_bib18","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1128\/JCM.00725-09","article-title":"Evaluation of a prototype real-time PCR assay for carcinogenic human papillomavirus (HPV) detection and simultaneous HPV genotype 16 (HPV16) and HPV18 genotyping","volume":"47","author":"Castel","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.tvr.2023.200255_bib19","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1470-2045(13)70570-9","article-title":"Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis","volume":"15","author":"Arbyn","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.tvr.2023.200255_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01239-18","article-title":"Clinical validation of the cobas HPV test on the cobas 6800 system for the purpose of cervical screening","volume":"57","author":"Saville","year":"2019","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.tvr.2023.200255_bib21","unstructured":"Australian Government, Department of Health. 2019. The Requirements for Laboratories Reporting Tests for the National Cervical Screening Program. second ed.. https:\/\/www1.health.gov.au\/internet\/main\/publishing.nsf\/Content\/npaac-cervical-screening (accessed 27 September 2022)."},{"key":"10.1016\/j.tvr.2023.200255_bib22","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1002\/ijc.28509","article-title":"Viral load and short-term natural history of type-specific oncogenic human papillomavirus infections in a high-risk cohort of midadult women","volume":"134","author":"Winer","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tvr.2023.200255_bib23","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/infdis\/jiq116","article-title":"Proyecto Epidemiol\u00f3gico Guanacaste Group, Long-term persistence of prevalently detected human papillomavirus infections in the absence of detectable cervical precancer and cancer","volume":"203","author":"Castle","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tvr.2023.200255_bib24","unstructured":"Linear Array HPV Genotyping Test Kit Insert, Doc Rec. 10.0."},{"key":"10.1016\/j.tvr.2023.200255_bib25","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1128\/JCM.03386-12","article-title":"Development and characterization of the cobas human papillomavirus test","volume":"51","author":"Rao","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.tvr.2023.200255_bib26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pvr.2017.10.002","article-title":"HPV genotype-specific concordance between EuroArray HPV, Anyplex II HPV28 and Linear Array HPV Genotyping test in Australian cervical samples","volume":"4","author":"Cornall","year":"2017","journal-title":"Papillomavirus. Res."},{"key":"10.1016\/j.tvr.2023.200255_bib27","doi-asserted-by":"crossref","first-page":"F100","DOI":"10.1016\/j.vaccine.2012.04.105","article-title":"Nucleic acid tests for the detection of alpha human papillomaviruses","volume":"30","author":"Poljak","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.tvr.2023.200255_bib28","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1016\/j.vaccine.2018.04.080","article-title":"Final analysis of a study assessing genital HPV genoprevalance in young Australian women, following eight years of a national vaccination program","volume":"36","author":"Garland","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.tvr.2023.200255_bib29","first-page":"1305","article-title":"Comparison of the Roche Cobas\u00ae 4800 HPV assay to Roche amplicor for detection of high-risk human papillomavirus","volume":"35","author":"Phillips","year":"2016","journal-title":"J.Clin. Microbiol. Infect"},{"key":"10.1016\/j.tvr.2023.200255_bib30","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/infdis\/jis590","article-title":"Fall in human papillomavirus prevalence following a national vaccination program","volume":"206","author":"Tabrizi","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tvr.2023.200255_bib31","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.vaccine.2018.11.075","article-title":"Age-specific HPV prevalence among 116,052 women in Australia's renewed cervical screening program: a new tool for monitoring vaccine impact,","volume":"37","author":"Brotherton","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.tvr.2023.200255_bib32","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/j.vaccine.2020.11.076","article-title":"Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence","volume":"39","author":"Brown","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.tvr.2023.200255_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.pvr.2019.100177","article-title":"Is one dose of human papillomavirus vaccine as effective as three? A national cohort analysis","volume":"8","author":"Brotherton","year":"2019","journal-title":"Papillomavirus Res."},{"key":"10.1016\/j.tvr.2023.200255_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104375","article-title":"Analytical performance of HPV assays on vaginal self-collected vs practitioner-collected cervical samples: the SCoPE study","volume":"127","author":"Saville","year":"2020","journal-title":"J. Clin. Virol."}],"container-title":["Tumour Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666679023000022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666679023000022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:53:16Z","timestamp":1763005996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666679023000022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":27,"alternative-id":["S2666679023000022"],"URL":"https:\/\/doi.org\/10.1016\/j.tvr.2023.200255","relation":{},"ISSN":["2666-6790"],"issn-type":[{"value":"2666-6790","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring monitoring strategies for population surveillance of HPV vaccine impact using primary HPV screening","name":"articletitle","label":"Article Title"},{"value":"Tumour Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tvr.2023.200255","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"200255"}}